GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $208,000 | +0.5% | 4,769 | +0.5% | 0.01% | 0.0% |
| Q1 2022 | $207,000 | -6.3% | 4,743 | -5.5% | 0.01% | 0.0% |
| Q4 2021 | $221,000 | +30.0% | 5,020 | +5.1% | 0.01% | +8.3% |
| Q1 2021 | $170,000 | +132.9% | 4,775 | +147.7% | 0.01% | +9.1% |
| Q1 2020 | $73,000 | -64.7% | 1,928 | -56.3% | 0.01% | -57.7% |
| Q4 2019 | $207,000 | +18.3% | 4,416 | +7.7% | 0.03% | +4.0% |
| Q3 2019 | $175,000 | -3.8% | 4,099 | -9.6% | 0.02% | -13.8% |
| Q2 2019 | $182,000 | +9.6% | 4,536 | +14.1% | 0.03% | +3.6% |
| Q1 2019 | $166,000 | +7.8% | 3,976 | -1.1% | 0.03% | -6.7% |
| Q4 2018 | $154,000 | +2.0% | 4,020 | +6.6% | 0.03% | +7.1% |
| Q3 2018 | $151,000 | -5.6% | 3,771 | -5.3% | 0.03% | -9.7% |
| Q2 2018 | $160,000 | +15.1% | 3,981 | +11.5% | 0.03% | 0.0% |
| Q1 2018 | $139,000 | +98.6% | 3,570 | +80.8% | 0.03% | +72.2% |
| Q4 2017 | $70,000 | -51.0% | 1,975 | -43.9% | 0.02% | -57.1% |
| Q3 2017 | $143,000 | +1942.9% | 3,520 | +1982.8% | 0.04% | +1300.0% |
| Q2 2017 | $7,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |